
epocrates
Trending Patient News: Week of February 7, 2026
February 13, 2026

Keeping you a step ahead is our priority. That's why we've gathered some of the top stories your patients might be seeing. Here are this week's highlights:
Hims & Hers drops plan for knockoff of Novo Nordisk’s new Wegovy weight loss pill
(AP)—Hims & Hers is backing off plans to offer a compounded version of Novo Nordisk’s oral semaglutide after federal regulators signaled increasing scrutiny. Read more
TikTok trend leaves 9‑year‑old boy with severe burns from microwaved ‘NeeDoh’ toy
(The Hill)—A social‑media challenge involving microwaving a popular squishy toy has led to serious injuries, prompting new warnings to parents. Read more
How to stay safe and stay warm in the cold
(ABC News)—With temperatures dropping, experts highlight essential steps to avoid frostbite, hypothermia, and heating‑related hazards. Read more
Dr. Mehmet Oz urges public to take the measles vaccine as U.S. cases rise
(PBS News)—As measles outbreaks grow, Dr. Oz is stressing the importance of vaccination to protect vulnerable communities. Read more
FDA declines to review Moderna’s application for first mRNA‑based flu vaccine
(NBC News)—Regulators have refused to review Moderna’s mRNA flu vaccine submission, delaying the company’s push into seasonal influenza prevention. Read more
James Van Der Beek shared colorectal cancer warning sign months before his death
(Fox News)—The late actor previously spoke publicly about a symptom of colorectal cancer, prompting renewed calls for early screening and awareness. Read more
Content availability may vary; some sources may require payment or registration.
Any views, thoughts, and opinions expressed in these articles are solely that of the publication and/or author and do not reflect the views, opinions, policies, or position of epocrates and athenahealth.
TRENDING THIS WEEK


